Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
AngioDynamics, Inc. - SIC # 3840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
ANGO
Nasdaq
3840
www.angiodynamics.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for AngioDynamics, Inc.
ANGO Q1 Earnings Beat Estimates on Med Tech Growth, Revenues Up Y/Y
- Oct 9th, 2026 7:58 am
AngioDynamics (ANGO) Q1 2027 Earnings Call Transcript
- Oct 8th, 2026 8:43 pm
AngioDynamics, Inc. Q1 2027 Earnings Call Summary
- Oct 8th, 2026 10:55 am
Why AngioDynamics Crashed Today
- Oct 8th, 2026 9:11 am
AngioDynamics Q1 Earnings Call Highlights
- Oct 8th, 2026 8:02 am
AngioDynamics Shares Fall 4.3% Despite Q1 Earnings Beat and Strong Med Tech Growth
- Oct 8th, 2026 6:19 am
AngioDynamics stock slips 4% despite beating estimates on Med Tech growth
- Oct 8th, 2026 4:51 am
AngioDynamics (ANGO) Reports Q1 Loss, Lags Revenue Estimates
- Oct 8th, 2026 4:15 am
AngioDynamics: Fiscal Q1 Earnings Snapshot
- Oct 8th, 2026 4:13 am
AngioDynamics Reports Fiscal Year 2027 First Quarter Financial Results; Continued Execution Drives Med Tech Growth and Profitability
- Oct 8th, 2026 4:02 am
AngioDynamics Announces Appointment of Eric Honroth as President and Chief Executive Officer
- Oct 8th, 2026 4:00 am
Delta Stock Struggles As Revenue Growth Accelerates; Will Its Results Pass Muster?
- Oct 2nd, 2026 6:00 am
AngioDynamics and The PERT Consortium® Name Jacobi Hospital as ALPHA-PE Research Fund Award Recipient to Advance Real-World Pulmonary Embolism Evidence
- Oct 2nd, 2026 4:00 am
AngioDynamics to Report Fiscal 2027 First Quarter Results on October 8, 2026
- Sep 28th, 2026 2:30 pm
AngioDynamics (ANGO) Up 8.9% Since Last Earnings Report: Can It Continue?
- Aug 13th, 2026 9:30 am
AngioDynamics Sees MedTech Becoming Majority of Revenue in Fiscal 2027
- Aug 11th, 2026 5:04 pm
Is ANGO a Buy as Med Tech Growth Battles Persistent Margin Pressure?
- Aug 6th, 2026 12:16 pm
ANGO's FY27 Guidance Puts Med Tech Growth and Tariff Risks in Focus
- Aug 6th, 2026 12:13 pm
ANGO Jumps 33.5% in 3 Months: Can the Rally Keep Going?
- Aug 6th, 2026 12:07 pm
Scroll